Diuretic Drug News and Research

RSS

A diuretic is any drug that elevates the rate of urination and thus provides a means of forced diuresis. There are several categories of diuretics. All diuretics increase the excretion of water from bodies, although each class does so in a distinct way.

Lower blood pressure to manage type 2 diabetes

A small reduction in blood pressure produced a significant benefit in the largest study ever done on the treatment of patients with type 2 diabetes, presented on Sunday in Vienna at the European Society of Cardiology Congress, and published online in the Lancet the same day.

5 Sep 2007

Blood pressure pill offers diabetics a longer life

A team of Australian researchers say a once-a-day pill to lower blood pressure should be given routinely to people with diabetes to prevent heart disease, strokes and other medical complications.

5 Sep 2007

Blood pressure drugs cut death rate in diabetes

The largest-ever study of treatments for diabetes has shown that a fixed combination of two blood pressure lowering drugs reduces the risk of death, as well as the risks of heart and kidney disease. Results from the ADVANCE (Action in Diabetes and Vascular Disease) Study were presented today at the European Society of Cardiology Congress 2007 in Vienna.

2 Sep 2007

Hypertension in the very elderly trial stopped

An international trial looking at the benefits of giving blood-pressure lowering medication to elderly patients has stopped early, after researchers observed significant reductions in overall mortality in those receiving treatment.

7 Aug 2007

Age-related hearing loss very common

For many people, hearing loss is part of aging. Hearing loss affects approximately one-third of people over age 65. Among people age 75 and older, 40 percent to 50 percent experience hearing loss.

7 Aug 2007

Low potassium levels linked to increased mortality in heart failure patients

New research from University of Alabama at Birmingham indicates that patients with heart failure who have low to low-normal serum potassium levels are at increased risk of death.

8 Jun 2007

Combination of medicines best for blood pressure control

Millions of Americans take medications for hypertension but do not achieve control of their blood pressure.

22 May 2007

Review of six large-scale clinical trials of aliskiren

Hypertension is a serious condition affecting millions.Currently there are seven classes of drugs used to reduce blood pressure. Aliskiren (Tekturna , Rasilez) is the first of a new class of orally active antihypertensive drugs that works by inhibiting renin.

10 May 2007

One out of four people don't know they have hypertension

High blood pressure is a major risk factor for heart attack, stroke, and renal failure, but one out of four people don't even know they have it.

2 May 2007

Laparoscopic dismembered pyeloplasty in children younger than 2 years

Laparoscopy has been implemented in the pediatric urologic population for many different operative interventions.

19 Apr 2007

New treatments and interventions for chronically impaired cardiac patients

Whether a patient is awaiting a heart transplant or living with chronic heart failure, cardiologists are continuously looking for new therapies that address short-term and/or long-term needs of chronically impaired cardiac patients.

30 Mar 2007

Tekturna new hypertension drug - first in a decade

The Food and Drug Administration (FDA) in the United States has given it's approval for the use of a new drug to treat hypertension.

7 Mar 2007

FDA approves Tekturna for the treatment of high blood pressure

The U.S. Food and Drug Administration (FDA) today announced the approval of Tekturna (aliskiren) tablets for the treatment of high blood pressure, or hypertension, which affects an estimated 25 percent of Americans and causes increased risk of stroke, heart attack, kidney failure, heart failure and death.

6 Mar 2007

Ranbaxy granted approval to manufacture Atenolol

Ranbaxy Laboratories has announced that the Company has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Atenolol Tablets USP, 25 mg, 50 mg, and 100 mg.

2 Jan 2007

Diabetes risk down three times with newer hypertension drugs

According to researchers patients given a mix of modern blood pressure drugs are one-third less likely to develop diabetes than those on older pills.

7 Sep 2006

One of the largest Japanese cardiovascular trials confirms angiotensin receptor blockade protects people who have a wide range of cardiovascular diseases

The first controlled large-scale intervention trial of angiotensin receptor blockade in Japanese patients has confirmed that the cardiovascular protective effects of the drug valsartan is greater than to those seen with other therapies giving the same level of blood pressure control.

5 Sep 2006

Gout is a significant independent risk factor of heart attack

First study to show that among men with no previous history of coronary artery disease, gout is a significant independent risk factor of heart attack.

2 Aug 2006

New guidelines for treating high blood pressure discounts beta-blockers

Drug treatment for high blood pressure is set to undergo a major shake-up after new guidance was issued for the NHS.

28 Jun 2006

Trandolapril and verapamil reduce risk of developing diabetes in Hispanic patients

The combination of drugs traditionally used to control blood pressure might not be ideal for Hispanic patients, University of Florida researchers warn.

23 May 2006

MDCT urography shows potential for detecting bladder cancer without surgery

MDCT urography is a promising technique for detecting bladder tumors both with and without contrast material, helping patients avoid an invasive test, according to a new study by researchers from the University of Michigan Health System in Ann Arbor, MI.

3 May 2006